Search

Your search keyword '"Baresic, M"' showing total 27 results

Search Constraints

Start Over You searched for: Author "Baresic, M" Remove constraint Author: "Baresic, M"
27 results on '"Baresic, M"'

Search Results

1. OP0238 IMMUNOSUPPRESSION WITH TARGETED DMARDS REDUCES MORBIDITY AND MORTALITY IN PRE-CAPILLARY PULMONARY HYPERTENSION ASSOCIATED WITH SYSTEMIC SCLEROSIS: A EUSTAR ANALYSIS

2. ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis

3. Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study

4. Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort

5. Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study

6. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis

7. Update of EULAR recommendations for the treatment of systemic sclerosis

8. What have multicentre registries across the world taught us about the disease features of systemic sclerosis?

9. Educational needs and preferences of young European clinicians and physician researchers working in the field of rheumatology

10. What have multicentre registries across the world taught us about the disease features of systemic sclerosis?.

11. Impress 2 (International multicentric prospective study on pregnancy in systemic sclerosis). Prospective, case-control study of pregnancy in systemic sclerosis

12. Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database

14. SAT0196 Impress 2 (International Multicentric Prospective Study on Pregnancy in Systemic Sclerosis). Prospective, Case-Control Study of Pregnancy in Systemic Sclerosis

15. Preliminary criteria for the very early diagnosis of systemic sclerosis: Results of a Delphi consensus study from EULAR scleroderma trials and research group

16. Catastrophic antiphospholipid syndrome associated with systemic lupus erythematosus treated with rituximab: case report and a review of the literature.

17. Catastrophic antiphospholipid syndrome associated with systemic lupus erythematosus treated with rituximab: case report and a review of the literature

18. Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study

19. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the european scleroderma trials and research (eustar) cohort

20. Phenotypes determined by cluster analysis and their survival in the prospective European Scleroderma Trials and Research cohort of patients with systemic sclerosis

21. Educational needs and preferences of young European clinicians and physician researchers working in the field of rheumatology

22. Misleading symptoms of hereditary angioedema type II mimicking familial mediterranean fever.

23. The Genomic Context and Corecruitment of SP1 Affect ERRα Coactivation by PGC-1α in Muscle Cells.

24. Transcriptional network analysis in muscle reveals AP-1 as a partner of PGC-1α in the regulation of the hypoxic gene program.

25. Rare zoonosis (hemotrophic mycoplasma infection) in a newly diagnosed systemic lupus erythematosus patient followed by a Nocardia asteroides pneumonia.

26. Survival after severe acute chromic acid poisoning complicated with renal and liver failure.

27. The Trypanosoma brucei cAMP phosphodiesterases TbrPDEB1 and TbrPDEB2: flagellar enzymes that are essential for parasite virulence.

Catalog

Books, media, physical & digital resources